Short and Long CB1 Agonist Exposures Differed in Their Receptor-Recovery Requirements

A laboratory receptor-trafficking study found that recovery after short agonist exposure did not require new protein synthesis, while recovery after longer exposure did. Exposure duration changed the recovery process, not merely the amount of internalization.

Agonists differed in internalization

WIN 55,212-2, CP55,940 and HU210 produced rapid CB1 internalization. Methanandamide required higher concentrations, while THC produced little internalization even at the tested high concentration. These results concern the experimental system and should not be converted directly into a ranking of human tolerance potential.

Recovery depended on the exposure interval

Return of receptors to the cell surface after 20 minutes of agonist treatment was independent of new protein synthesis. The same was not true after 90 minutes. Recycling also required endosomal acidification and dephosphorylation. Surface recovery therefore involved regulated processes rather than passive movement alone.

Structural manipulations narrowed the mechanism

A receptor missing its final 14 residues did not internalize, while one missing its final 10 did. Hypertonic sucrose inhibited sequestration, supporting a clathrin-associated route. Activated Gi, Go and Gs alpha subunits were not required for internalization in the tested comparisons.

The study's focused contribution is that receptor recovery can change qualitatively with exposure duration. It does not establish how long a person should abstain from cannabis or show that THC tolerance requires extensive internalization. Cellular trafficking, behavioral tolerance and clinical recovery remain different levels of evidence.

Related: interpreting cannabis tolerance claims.

Research cited

Hsieh C; Brown S; Derleth C; Mackie K. Internalization and recycling of the CB1 cannabinoid receptor. Journal of neurochemistry (1999). doi:10.1046/j.1471-4159.1999.0730493.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us